イシグロ　タイチ   ISHIGURO Taichi   石黒　太一    所属   医学部 医学科（附属八千代医療センター）    職種   准教授
論文種別	原著
言語種別	英語
査読の有無	査読あり
招待の有無	招待あり
表題	Middle meningeal artery embolization for chronic subdural hematoma: a systematic review.
掲載誌名	正式名：Frontiers in neurology 略　 称：Front Neurol ISSNコード：16642295/16642295
掲載区分	国外
巻・号・頁	14,pp.1259647
著者・共著者	Omura Yoshihiro, Ishiguro Taichi
担当区分	責任著者
発行年月	2023
概要	BACKGROUND:Chronic subdural hematoma (cSDH) is one of the most common diseases in neurosurgery. Middle meningeal artery embolization (MMAE) is reportedly an option to prevent recurrence or avoid surgery in patients with cSDH. This study was performed to review the evidence on MMAE for cSDH and evaluate its safety, efficacy, indications, and feasibility.METHODS:We systematically reviewed the literature according to the PRISMA guidelines using an electronic database. The search yielded 43 articles involving 2,783 patients who underwent MMAE.RESULTS:The hematoma resolution, recurrence, and retreatment rates in the MMAE-alone treatment group (n = 815) were 86.7%, 6.3%, and 9.6%, respectively, whereas those in the prophylactic MMAE with combined surgery group (n = 370) were 95.6%, 4.4%, and 3.4%, respectively. The overall MMAE-related complication rate was 2.3%.CONCLUSION:This study shows that MMAE alone is, although not immediate, as effective as evacuation surgery alone in reducing hematoma. The study also shows that combined treatment has a lower recurrence rate than evacuation surgery alone. Because MMAE is a safe procedure, it should be considered for patients with cSDH, especially those with a high risk of recurrence.
DOI	10.3389/fneur.2023.1259647
PMID	37881312